|Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary …|
Gastroenterology 113, 1146-58, 1997
|Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database|
BA Thompson, AB Spurdle, JP Plazzer, MS Greenblatt, K Akagi, ...
Nature genetics 46 (2), 107-115, 2014
|Molecular pathways in colorectal cancer|
S Al‐Sohaily, A Biankin, R Leong, M Kohonen‐Corish, J Warusavitarne
Journal of gastroenterology and hepatology 27 (9), 1423-1431, 2012
|PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma|
WA Cooper, T Tran, RE Vilain, J Madore, CI Selinger, M Kohonen-Corish, ...
Lung cancer 89 (2), 181-188, 2015
|Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1.|
NM Raevaara TE, Korhonen MK, Lohi H, Hampel H, Lynch E, Lonnqvist KE ...
Gastroenterology 129, 537-49, 2005
|Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis|
C Vennin, VT Chin, SC Warren, MC Lucas, D Herrmann, A Magenau, ...
Science translational medicine 9 (384), 2017
|Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization|
CI Selinger, TM Rogers, PA Russell, S O'toole, PY Yip, GM Wright, ...
Modern pathology 26 (12), 1545-1553, 2013
|Immunodeficient mice recover from infection with vaccinia virus expressing interferon‐γ|
MRJ Kohonen‐Corish, NJC King, CE Woodhams, IA Ramshaw
European journal of immunology 20 (1), 157-161, 1990
|Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary …|
H Van Der Klift, J Wijnen, A Wagner, P Verkuilen, C Tops, R Otway, ...
Genes, Chromosomes and cancer 44 (2), 123-138, 2005
|Low microsatellite instability is associated with poor prognosis in stage C colon cancer|
MRJ Kohonen-Corish, JJ Daniel, C Chan, BPC Lin, SY Kwun, OF Dent, ...
Journal of Clinical Oncology 23 (10), 2318-2324, 2005
|Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo.|
SK Sambhi, MR Kohonen-Corish, IA Ramshaw
Proceedings of the National Academy of Sciences 88 (9), 4025-4029, 1991
|Analysis of Australian Crohn's disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16|
JA Cavanaugh, DF Callen, SR Wilson, PM Stanford, ME Sraml, M Gorska, ...
Annals of human genetics 62 (4), 291-298, 1998
|DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma|
TJ Seng, N Currey, WA Cooper, CS Lee, C Chan, L Horvath, ...
British journal of cancer 99 (2), 375-382, 2008
|RNA-based mutation screening in hereditary nonpolyposis colorectal cancer.|
M Kohonen-Corish, VL Ross, WF Doe, DA Kool, E Edkins, I Faragher, ...
American journal of human genetics 59 (4), 818, 1996
|Expression and prognostic significance of cyclin B1 and cyclin A in non‐small cell lung cancer|
WA Cooper, MRJ Kohonen‐Corish, B McCaughan, C Kennedy, ...
Histopathology 55 (1), 28-36, 2009
|Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer|
CI Selinger, WA Cooper, S Al-Sohaily, DN Mladenova, L Pangon, ...
Journal of thoracic oncology 6 (7), 1179-1189, 2011
|Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancer|
MRJ Kohonen-Corish, ND Sigglekow, J Susanto, PH Chapuis, EL Bokey, ...
Oncogene 26 (30), 4435-4441, 2007
|Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer|
TN Tran, CI Selinger, MRJ Kohonen-Corish, BC McCaughan, ...
Lung cancer 81 (3), 462-467, 2013
|Interleukin‐5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo|
AJ Ramsay, M Kohonen‐Corish
European journal of immunology 23 (12), 3141-3145, 1993
|Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein|
S Ollila, L Sarantaus, R Kariola, P Chan, H Hampel, E Holinski–Feder, ...
Gastroenterology 131 (5), 1408-1417, 2006